BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 19659439)

  • 1. Zygomycosis in solid organ transplant recipients: a prospective, matched case-control study to assess risks for disease and outcome.
    Singh N; Aguado JM; Bonatti H; Forrest G; Gupta KL; Safdar N; John GT; Pursell KJ; Muñoz P; Patel R; Fortun J; Martin-Davila P; Philippe B; Philit F; Tabah A; Terzi N; Chatelet V; Kusne S; Clark N; Blumberg E; Julia MB; Humar A; Houston S; Lass-Flörl C; Johnson L; Dubberke ER; Barron MA; Lortholary O
    J Infect Dis; 2009 Sep; 200(6):1002-11. PubMed ID: 19659439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Invasive zygomycosis in transplant recipients.
    Uçkay I; Chalandon Y; Sartoretti P; Rohner P; Berney T; Hadaya K; van Delden C
    Clin Transplant; 2007; 21(4):577-82. PubMed ID: 17645724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in the spectrum and risk factors for invasive candidiasis in liver transplant recipients: prospective, multicenter, case-controlled study.
    Husain S; Tollemar J; Dominguez EA; Baumgarten K; Humar A; Paterson DL; Wagener MM; Kusne S; Singh N
    Transplantation; 2003 Jun; 75(12):2023-9. PubMed ID: 12829905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Forty-one recent cases of invasive zygomycosis from a global clinical registry.
    Rüping MJ; Heinz WJ; Kindo AJ; Rickerts V; Lass-Flörl C; Beisel C; Herbrecht R; Roth Y; Silling G; Ullmann AJ; Borchert K; Egerer G; Maertens J; Maschmeyer G; Simon A; Wattad M; Fischer G; Vehreschild JJ; Cornely OA
    J Antimicrob Chemother; 2010 Feb; 65(2):296-302. PubMed ID: 20008047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging importance of infections due to zygomycetes in organ transplant recipients.
    Sun HY; Singh N
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S115-8. PubMed ID: 19013334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zygomycosis and other rare filamentous fungal infections in solid organ transplant recipients.
    Stelzmueller I; Lass-Floerl C; Geltner C; Graziadei I; Schneeberger S; Antretter H; Mueller L; Zelger B; Singh N; Pruett TL; Margreiter R; Bonatti H
    Transpl Int; 2008 Jun; 21(6):534-46. PubMed ID: 18363572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases.
    Kontoyiannis DP; Lionakis MS; Lewis RE; Chamilos G; Healy M; Perego C; Safdar A; Kantarjian H; Champlin R; Walsh TJ; Raad II
    J Infect Dis; 2005 Apr; 191(8):1350-60. PubMed ID: 15776383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors, clinical characteristics, and outcomes of invasive fungal infections in solid organ transplant recipients.
    Bodro M; Sabé N; Gomila A; Ayats J; Baliellas C; Roca J; Melilli E; Carratalà J
    Transplant Proc; 2012 Nov; 44(9):2682-5. PubMed ID: 23146493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Invasive zygomycosis in hematopoietic stem cell transplant recipients receiving voriconazole prophylaxis.
    Siwek GT; Dodgson KJ; de Magalhaes-Silverman M; Bartelt LA; Kilborn SB; Hoth PL; Diekema DJ; Pfaller MA
    Clin Infect Dis; 2004 Aug; 39(4):584-7. PubMed ID: 15356827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors, clinical features, and outcomes of listeriosis in solid-organ transplant recipients: a matched case-control study.
    Fernàndez-Sabé N; Cervera C; López-Medrano F; Llano M; Sáez E; Len O; Fortún J; Blanes M; Laporta R; Torre-Cisneros J; Gavaldà J; Muñoz P; Fariñas MC; María Aguado J; Moreno A; Carratalà J
    Clin Infect Dis; 2009 Oct; 49(8):1153-9. PubMed ID: 19751149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors, clinical characteristics, and outcome of Nocardia infection in organ transplant recipients: a matched case-control study.
    Peleg AY; Husain S; Qureshi ZA; Silveira FP; Sarumi M; Shutt KA; Kwak EJ; Paterson DL
    Clin Infect Dis; 2007 May; 44(10):1307-14. PubMed ID: 17443467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of invasive zygomycosis infections in renal transplant recipients.
    Forrest GN; Mankes K
    Transpl Infect Dis; 2007 Jun; 9(2):161-4. PubMed ID: 17462005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histoplasmosis in solid organ transplant recipients: 10 years of experience at a large transplant center in an endemic area.
    Cuellar-Rodriguez J; Avery RK; Lard M; Budev M; Gordon SM; Shrestha NK; van Duin D; Oethinger M; Mawhorter SD
    Clin Infect Dis; 2009 Sep; 49(5):710-6. PubMed ID: 19635026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infections due to Scedosporium apiospermum and Scedosporium prolificans in transplant recipients: clinical characteristics and impact of antifungal agent therapy on outcome.
    Husain S; Muñoz P; Forrest G; Alexander BD; Somani J; Brennan K; Wagener MM; Singh N
    Clin Infect Dis; 2005 Jan; 40(1):89-99. PubMed ID: 15614697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rhino-orbital-cerebral zygomycosis in solid organ transplant recipients.
    Sun HY; Forrest G; Gupta KL; Aguado JM; Lortholary O; Julia MB; Safdar N; Patel R; Kusne S; Singh N
    Transplantation; 2010 Jul; 90(1):85-92. PubMed ID: 20626095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opportunistic mycelial fungal infections in organ transplant recipients: emerging importance of non-Aspergillus mycelial fungi.
    Husain S; Alexander BD; Munoz P; Avery RK; Houston S; Pruett T; Jacobs R; Dominguez EA; Tollemar JG; Baumgarten K; Yu CM; Wagener MM; Linden P; Kusne S; Singh N
    Clin Infect Dis; 2003 Jul; 37(2):221-9. PubMed ID: 12856215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry.
    Neofytos D; Horn D; Anaissie E; Steinbach W; Olyaei A; Fishman J; Pfaller M; Chang C; Webster K; Marr K
    Clin Infect Dis; 2009 Feb; 48(3):265-73. PubMed ID: 19115967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Posaconazole as salvage therapy in patients with invasive fungal infections after solid organ transplant.
    Alexander BD; Perfect JR; Daly JS; Restrepo A; Tobón AM; Patino H; Hardalo CJ; Graybill JR
    Transplantation; 2008 Sep; 86(6):791-6. PubMed ID: 18813103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cryptococcosis in solid-organ, hematopoietic stem cell, and tissue transplant recipients: evidence-based evolving trends.
    Sun HY; Wagener MM; Singh N
    Clin Infect Dis; 2009 Jun; 48(11):1566-76. PubMed ID: 19402789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of zygomycosis in transplant recipients.
    Cuenca-Estrella M; Bernal-Martinez L; Isla G; Gomez-Lopez A; Alcazar-Fuoli L; Buitrago MJ
    Clin Microbiol Infect; 2009 Oct; 15 Suppl 5():37-40. PubMed ID: 19754755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.